Ward P, Noyce P, St Leger A
Int J Equity Health. 2007; 6:2.
PMID: 17386118
PMC: 1847516.
DOI: 10.1186/1475-9276-6-2.
Warburton R
BMJ. 2003; 327(7426):1237-8.
PMID: 14644934
PMC: 286232.
DOI: 10.1136/bmj.327.7426.1237.
Cordon Granados F, Solanas Saura P
Aten Primaria. 2002; 30(1):29-31.
PMID: 12106577
PMC: 7679559.
DOI: 10.1016/s0212-6567(02)78960-9.
Reid F, Cook D, Whincup P
Heart. 2002; 88(1):15-9.
PMID: 12067933
PMC: 1767198.
DOI: 10.1136/heart.88.1.15.
Freemantle N, Hill S
BMJ. 2002; 324(7342):864-5.
PMID: 11950720
PMC: 1122818.
DOI: 10.1136/bmj.324.7342.864.
The impact of health economics on healthcare delivery: the health economists' perspective.
McDonald R, Haycox A, Walley T
Pharmacoeconomics. 2001; 19(8):803-9.
PMID: 11596832
DOI: 10.2165/00019053-200119080-00002.
Developing guidance for budget impact analysis.
Trueman P, Drummond M, Hutton J
Pharmacoeconomics. 2001; 19(6):609-21.
PMID: 11456210
DOI: 10.2165/00019053-200119060-00001.
[The quality of the drug treatment in hyperlipemia patients from 4 health areas. The VICAF Group].
Sanz Cuesta T, Escortell Mayor E, Fernandez San Martin M, Lopez Bilbao C, Medina Bustillo B, Torres Bouza C
Aten Primaria. 2000; 26(6):368-73.
PMID: 11111308
PMC: 7681478.
DOI: 10.1016/s0212-6567(00)78685-9.
The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care.
Hippisley-Cox J, Pringle M
Br J Gen Pract. 2000; 50(458):699-705.
PMID: 11050784
PMC: 1313796.
Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.
Kernick D
Br J Gen Pract. 2000; 50(458):697-8.
PMID: 11050783
PMC: 1313795.
The primary prevention of coronary heart disease with statins: practice headache or public health?.
Evans P
Br J Gen Pract. 2000; 50(458):695-7.
PMID: 11050782
PMC: 1313794.
Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.
Ritchie L
Br J Gen Pract. 2000; 50(458):693-5.
PMID: 11050781
PMC: 1313793.
Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.
Freemantle N, Mason J
BMJ. 1999; 318(7196):1480-2.
PMID: 10346779
PMC: 1115847.
DOI: 10.1136/bmj.318.7196.1480.
Applying the Sheffield tables to data from general practice.
Muir J, Fuller A, Lancaster T
Br J Gen Pract. 1999; 49(440):217-8.
PMID: 10343427
PMC: 1313376.
Clinical guidelines-the hidden costs.
Haycox A, Bagust A, Walley T
BMJ. 1999; 318(7180):391-3.
PMID: 9933210
PMC: 1114849.
DOI: 10.1136/bmj.318.7180.391.
A simple computer program for guiding management of cardiovascular risk factors and prescribing.
Hingorani A, Vallance P
BMJ. 1999; 318(7176):101-5.
PMID: 9880285
PMC: 34545.
DOI: 10.1136/bmj.318.7176.101.
From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia.
Fairhurst K, Huby G
BMJ. 1998; 317(7166):1130-4.
PMID: 9784451
PMC: 28696.
DOI: 10.1136/bmj.317.7166.1130.
Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: cross sectional study of cardiovascular disease and risk factors.
Unwin N, Thomson R, OByrne A, Laker M, Armstrong H
BMJ. 1998; 317(7166):1125-30.
PMID: 9784450
PMC: 28695.
DOI: 10.1136/bmj.317.7166.1125.
Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
Pharoah P
BMJ. 1998; 316(7139):1241-2.
PMID: 9553009
PMC: 1112994.
Patients offered treatment for CHD need full information to make decision.
McCormack J, Levine M, Rangno R, McCormack P
BMJ. 1998; 316(7136):1021-2.
PMID: 9550986
PMC: 1112867.
